Announcing the first novel class of rapid-onset antidepressants in clinical practice
| Autor: | Oluwatosin Beatrice Ibiyemi-Fasipe, Peter Ehizokhale Akhideno, Olumuyiwa John Fasipe, Omagbemi Sampson Owhin |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Class (computer programming)
050402 sociology business.industry 05 social sciences 030206 dentistry General Medicine Serotonergic Clinical Practice 03 medical and health sciences Glutamatergic 0302 clinical medicine 0504 sociology Rapid onset Medicine Dopaminergic neurotransmission business Neuroscience |
| Zdroj: | Journal of Medical Sciences. 39:205 |
| ISSN: | 1011-4564 |
| Popis: | This study was designed with the rational aim/purpose of announcing and discussing the new class of rapid-onset antidepressants that will bring forth significant improvement and positive impact to the management of patients with depression disorders in clinical practice. The class of N-methyl-D-aspartate-glutamatergic ionoceptor blockers represent the first separate novel class of rapid-onset antidepressants with a direct action on the excitatory glutamatergic neurotransmission system but no direct action on the serotonergic, noradrenergic, or dopaminergic neurotransmission systems. It consistently fits into the antidepressants' classification nomenclature, and the pharmacological properties also deemed it appropriate to be accepted and announced as the first separate novel class of rapid-onset antidepressants. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|